- Home
- VNDA vs SNFCA Comparison
VNDA vs SNFCA Comparison
Compare VNDA & SNFCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- SNFCA
- Stock Information
- Founded
- VNDA 2002
- SNFCA 1965
- Country
- VNDA United States
- SNFCA United States
- Employees
- VNDA N/A
- SNFCA N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- SNFCA Finance: Consumer Services
- Sector
- VNDA Health Care
- SNFCA Finance
- Exchange
- VNDA Nasdaq
- SNFCA Nasdaq
- Market Cap
- VNDA 237.9M
- SNFCA 224.4M
- IPO Year
- VNDA 2006
- SNFCA N/A
- Fundamental
- Price
- VNDA $4.33
- SNFCA $8.96
- Analyst Decision
- VNDA Strong Buy
- SNFCA
- Analyst Count
- VNDA 2
- SNFCA 0
- Target Price
- VNDA $16.50
- SNFCA N/A
- AVG Volume (30 Days)
- VNDA 754.6K
- SNFCA 48.0K
- Earning Date
- VNDA 05-07-2025
- SNFCA 05-13-2025
- Dividend Yield
- VNDA N/A
- SNFCA N/A
- EPS Growth
- VNDA N/A
- SNFCA 81.97
- EPS
- VNDA N/A
- SNFCA 1.11
- Revenue
- VNDA $198,772,000.00
- SNFCA $334,522,668.00
- Revenue This Year
- VNDA $14.36
- SNFCA N/A
- Revenue Next Year
- VNDA $44.53
- SNFCA N/A
- P/E Ratio
- VNDA N/A
- SNFCA $8.07
- Revenue Growth
- VNDA 3.18
- SNFCA 5.03
- 52 Week Low
- VNDA $3.85
- SNFCA $6.19
- 52 Week High
- VNDA $6.75
- SNFCA $13.59
- Technical
- Relative Strength Index (RSI)
- VNDA 43.42
- SNFCA 24.08
- Support Level
- VNDA $4.27
- SNFCA $8.92
- Resistance Level
- VNDA $4.46
- SNFCA $9.51
- Average True Range (ATR)
- VNDA 0.22
- SNFCA 0.67
- MACD
- VNDA 0.01
- SNFCA -0.12
- Stochastic Oscillator
- VNDA 54.55
- SNFCA 27.37
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About SNFCA Security National Financial Corporation
Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.